Kalavalapalli S - Search Results

1

Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.

Kalavalapalli S, Leiva EG, Lomonaco R, Chi X, Shrestha S, Dillard R, Budd J, Romero JP, Li C, Bril F, Samraj G, Pennington J, Townsend P, Orlando F, Shetty S, Mansour L, Silva-Sombra LR, Bedossa P, Malaty J, Barb D, Gurka MJ, Cusi K. Kalavalapalli S, et al. J Clin Endocrinol Metab. 2023 Apr 13;108(5):1192-1201. doi: 10.1210/clinem/dgac660. J Clin Endocrinol Metab. 2023. PMID: 36378995

2

Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.

Sunny NE, Kalavalapalli S, Bril F, Garrett TJ, Nautiyal M, Mathew JT, Williams CM, Cusi K. Sunny NE, et al. Among authors: kalavalapalli s. Am J Physiol Endocrinol Metab. 2015 Aug 15;309(4):E311-9. doi: 10.1152/ajpendo.00161.2015. Epub 2015 Jun 9. Am J Physiol Endocrinol Metab. 2015. PMID: 26058864 Free PMC article. Clinical Trial.

3

Plasma thyroid hormone concentration is associated with hepatic triglyceride content in patients with type 2 diabetes.

Bril F, Kadiyala S, Portillo Sanchez P, Sunny NE, Biernacki D, Maximos M, Kalavalapalli S, Lomonaco R, Suman A, Cusi K. Bril F, et al. Among authors: kalavalapalli s. J Investig Med. 2016 Jan;64(1):63-8. doi: 10.1136/jim-2015-000019. Epub 2015 Dec 16. J Investig Med. 2016. PMID: 26755815

4

Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.

Patterson RE, Kalavalapalli S, Williams CM, Nautiyal M, Mathew JT, Martinez J, Reinhard MK, McDougall DJ, Rocca JR, Yost RA, Cusi K, Garrett TJ, Sunny NE. Patterson RE, et al. Among authors: kalavalapalli s. Am J Physiol Endocrinol Metab. 2016 Apr 1;310(7):E484-94. doi: 10.1152/ajpendo.00492.2015. Epub 2016 Jan 26. Am J Physiol Endocrinol Metab. 2016. PMID: 26814015 Free PMC article.

5

Concentration-dependent response to pioglitazone in nonalcoholic steatohepatitis.

Kawaguchi-Suzuki M, Bril F, Kalavalapalli S, Cusi K, Frye RF. Kawaguchi-Suzuki M, et al. Among authors: kalavalapalli s. Aliment Pharmacol Ther. 2017 Jul;46(1):56-61. doi: 10.1111/apt.14111. Epub 2017 May 3. Aliment Pharmacol Ther. 2017. PMID: 28470881 Free PMC article.

6

Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients.

Bril F, Portillo-Sanchez P, Liu IC, Kalavalapalli S, Dayton K, Cusi K. Bril F, et al. Among authors: kalavalapalli s. Diabetes Care. 2018 Jan;41(1):187-192. doi: 10.2337/dc17-1349. Epub 2017 Nov 13. Diabetes Care. 2018. PMID: 29133343

7

Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes.

Bril F, Kalavalapalli S, Clark VC, Lomonaco R, Soldevila-Pico C, Liu IC, Orsak B, Tio F, Cusi K. Bril F, et al. Among authors: kalavalapalli s. Clin Gastroenterol Hepatol. 2018 Apr;16(4):558-566.e2. doi: 10.1016/j.cgh.2017.12.001. Epub 2017 Dec 7. Clin Gastroenterol Hepatol. 2018. PMID: 29223443

8

Use of a metabolomic approach to non-invasively diagnose non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus.

Bril F, Millán L, Kalavalapalli S, McPhaul MJ, Caulfield MP, Martinez-Arranz I, Alonso C, Ortiz Betes P, Mato JM, Cusi K. Bril F, et al. Among authors: kalavalapalli s. Diabetes Obes Metab. 2018 Jul;20(7):1702-1709. doi: 10.1111/dom.13285. Epub 2018 Apr 14. Diabetes Obes Metab. 2018. PMID: 29527789

9

Pioglitazone improves hepatic mitochondrial function in a mouse model of nonalcoholic steatohepatitis.

Kalavalapalli S, Bril F, Koelmel JP, Abdo K, Guingab J, Andrews P, Li WY, Jose D, Yost RA, Frye RF, Garrett TJ, Cusi K, Sunny NE. Kalavalapalli S, et al. Am J Physiol Endocrinol Metab. 2018 Aug 1;315(2):E163-E173. doi: 10.1152/ajpendo.00023.2018. Epub 2018 Apr 10. Am J Physiol Endocrinol Metab. 2018. PMID: 29634314 Free PMC article.

10

Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes.

Cusi K, Bril F, Barb D, Polidori D, Sha S, Ghosh A, Farrell K, Sunny NE, Kalavalapalli S, Pettus J, Ciaraldi TP, Mudaliar S, Henry RR. Cusi K, et al. Among authors: kalavalapalli s. Diabetes Obes Metab. 2019 Apr;21(4):812-821. doi: 10.1111/dom.13584. Epub 2018 Dec 18. Diabetes Obes Metab. 2019. PMID: 30447037 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page